By a combination of genetic, biochemical, and ultrastructural approaches, we provide here compelling evidence for the involvement of
lipid raft aggregates containing recruited Fas/CD95
death receptor, Fas-associated death domain-containing
protein (FADD), and
procaspase-8 in the induction of apoptosis in human
T-cell leukemia Jurkat cells by the
antitumor drug edelfosine, the prototype compound of a promising family of synthetic antitumor
lipids named as synthetic alkyl-
lysophospholipid analogues. Co-immunoprecipitation assays revealed that
edelfosine induced the generation of the so-called death-inducing signaling complex (DISC), made up of Fas/CD95, FADD, and
procaspase-8, in
lipid rafts. Electron microscopy analyses allowed to visualize the formation of raft clusters and their co-localization with DISC components Fas/CD95, FADD, and
procaspase-8 following
edelfosine treatment of Jurkat cells. Silencing of Fas/CD95 by RNA interference, transfection with a FADD dominant-negative mutant that blocks Fas/CD95 signaling, and specific inhibition of
caspase-8 prevented the apoptotic response triggered by
edelfosine, hence demonstrating the functional role of DISC in drug-induced apoptosis. By using radioactive labeled
edelfosine and a fluorescent analogue, we found that
edelfosine accumulated in
lipid rafts, forming
edelfosine-rich membrane raft clusters in Jurkat leukemic T-cells. Disruption of these membrane raft domains abrogated drug uptake and drug-induced DISC assembly and apoptosis. Thus,
edelfosine uptake into
lipid rafts was critical for the onset of both co-aggregation of DISC in membrane rafts and subsequent apoptotic cell death.
CONCLUSIONS/SIGNIFICANCE: